This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Fibroadenosis (breast)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Fibroadenosis or fibrocystic disease is the most common cause of breast lumps in women of reproductive age. The peak incidence is between 35 and 50 years of age. It is rare before 25 years.

The term embraces a spectrum of histologic changes, and may encompass many patients who have cystic lesions detected clinically or sclerotic breast lesions detected on mammography as discussed elsewhere.

Histologically it is characterized by overgrowth of both fibrous stroma, and of epithelial elements i.e. ducts and lobules, in differing proportions. These changes may be considered as abberations of normal breast involution and not part of a disease process. The condition may be due to a disordered or imbalanced response to endogenous sex hormones.

Only in those cases showing marked epithelial hyperplasia - epitheliosis - is the risk of breast carcinoma thought to be increased.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.